Article

A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa

Published in: South African Family Practice
Volume 57 , issue 2 , 2015 , pages: 57–61

DOI: 10.1080/20786190.2014.978121

Author(s): A Randjelovic Faculty of Medicine, Norway , SG Frønæs Faculty of Medicine, Norway , M Munsami The Kwazulu-Natal Department of Health, South Africa , JD Kvalsvig Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa , SG Zulu Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa , S Gagai Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa , A Maphumulo Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa , L Sandvik Department of Biostatistics, Epidemiology and Health Economics, Norway , SG Gundersen Research Department, Norway , EF Kjetland Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa , M Taylor Discipline of Public Health Medicine, Nelson R Mandela School of Medicine, South Africa

Keywords: health education , mass drug administration , mass-treatment , praziquantel , rural health , schistosomiasis , treatment

Download full text Get new issue alerts

Abstract

Background: It has been estimated that 700 million people worldwide and 5.2 million people in South Africa are in need of annual treatment for schistosomiasis. In accordance with the current policy the Department of Health (DoH) in KwaZulu-Natal province, South Africa, aimed to reach 75% treatment coverage in a mass treatment campaign (MTC) of schools in a schistosomiasis-endemic area.

« License to cut and kill practice: a case report on botched circumcision in Mthatha region of South Africa

Self-prescription practices by Nigerian medical doctors »